BTAI icon

BioXcel Therapeutics

108 hedge funds and large institutions have $378M invested in BioXcel Therapeutics in 2021 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

25% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 32

38% less call options, than puts

Call options by funds: $4.94M | Put options by funds: $7.94M

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.94M
Puts
$7.94M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$90.5M
2
$42.4M
3
$34.7M
4
$32.9M
5
$27.4M
6
$26.2M
7
$8.36M
8
$8.04M
9
$7.96M
10
$6.75M
11
$6.54M
12
$6.24M
13
$5.25M
14
$5.16M
15
$4.67M
16
$4.57M
17
$4.36M
18
$3.81M
19
$3.47M
20
$3.03M
21
$2.99M
22
$2.91M
23
$2.31M
24
$2.29M
25
$2M